World's Best Scientists 2026 revealed!
Roberto S. Accolla

Roberto S. Accolla

D-Index & Metrics

Immunology

D-Index
51
Citations
8944
World Ranking
4152
National Ranking
174

Roberto S. Accolla publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Roberto S. Accolla sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 282 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Roberto S. Accolla D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Roberto S. Accolla sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Roberto S. Accolla is affiliated with the University of Insubria in Italy. Their research spans primarily the fields of Immunology and Microbiology as well as Medicine, with a focus on subfields such as Immunology, Infectious Diseases, and Oncology.

The scientist's work covers a variety of topics, including:

  • Immunotherapy and Immune Responses
  • T-cell and Retrovirus Studies
  • SARS-CoV-2 and COVID-19 Research
  • Animal Disease Management and Epidemiology
  • Vector-Borne Animal Diseases
  • Cancer Immunotherapy and Biomarkers
  • Bacterial Infections and Vaccines

Their recent publications include:

  • Mucosal immune response in BNT162b2 COVID-19 vaccine recipients, 2021, EBioMedicine
  • HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models, 2021, International Journal of Molecular Sciences
  • Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine, 2023, EBioMedicine
  • CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens, 2020, Molecular & Cellular Proteomics
  • The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy, 2023, Biomedical Journal

Roberto S. Accolla frequently collaborates with other researchers. Notable frequent co-authors include:

  • Greta Forlani
  • Mariam Shallak
  • Lorenzo Azzi
  • Daniela Dalla Gasperina
  • Giovanni Veronesi

The scientist's work is published predominantly in:

  • Frontiers in Immunology
  • EBioMedicine
  • International Journal of Molecular Sciences
  • Journal of Translational Medicine
  • SSRN Electronic Journal

Best Publications

  • CIITA-Induced MHC Class II Expression in Mammary Adenocarcinoma Leads to a Th1 Polarization of the Tumor Microenvironment, Tumor Rejection, and Specific Antitumor Memory

    Lorenzo Mortara;Patrizia Castellani;Raffaella Meazza;Giovanna Tosi

  • Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy

    Jean-Pierre Mach;Jean-Pierre Mach;Jean-Pierre Mach;Franz Buchegger;Franz Buchegger;Franz Buchegger;Michel Forni;Michel Forni;Michel Forni;Jurg Ritschard;Jurg Ritschard;Jurg Ritschard

  • Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells

    M. C. Mingari;F. Gerosa;G. Carra;R. S. Accolla

  • Common human melanoma-associated antigen(s) detected by monoclonal antibodies.

    Stefan Carrel;Roberto S. Accolla;Anna L. Carmagnola;Jean-Pierre Mach

  • Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets.

    Roberto S. Accolla

  • Mucosal immune response in BNT162b2 COVID-19 vaccine recipients

    Unknown

  • Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

    Gilberto Filaci;Marco Fravega;Simone Negrini;Francesco Procopio

  • Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines

    Roberto S. Accolla;Stefan Carrel;Jean-Pierre Mach

  • Subsets of human Ia-like molecules defined by monoclonal antibodies.

    Stefan Carrel;Roberto Tosi;Nicole Gross;Noboyuki Tanigaki

  • The genes for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) are tandemly arranged on chromosome 17 of the mouse

    S. A. Nedospasov;B. Hirt;A. N. Shakhov;V. N. Dobrynin

  • Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak crossreacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb

    Najet Rebai;Bernard Malissen;Michel Pierres;Roberto S. Accolla

  • Human Glioma-associated Antigens Detected by Monoclonal Antibodies

    J F Schnegg;A C Diserens;S Carrel;R S Accolla

  • Reducing the global burden of HTLV-1 infection: An agenda for research and action.

    Luc Willems;Hideki Hasegawa;Roberto Accolla;Charles Bangham

  • Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response.

    Barbara Morandi;Lorenzo Mortara;Laura Chiossone;Roberto S. Accolla

  • Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.

    Thomas Herrmann;Roberto S. Accolla;H. Robson MacDonald

  • aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.

    Roberto S. Accolla;Martine Jotterand-Bellomo;Leo Scarpellino;Antonella Maffei

  • Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells.

    Raffaella Meazza;Alberto Comes;Anna M. Orengo;Silvano Ferrini

  • Isolation of distinct cDNA clones encoding HLA-DR beta chains by use of an expression assay.

    Eric O. Long;Claire T. Wake;Michel Strubin;Nicole Gross

  • Targeted delivery of tumor necrosis factor-α to tumor vessels induces a therapeutic T cell - mediated immune response that protects the host against syngeneic tumors of different histologic origin

    Enrica Balza;Lorenzo Mortara;Francesca Sassi;Stefano Monteghirfo

  • Distinct forms of both alpha and beta subunits are present in the human Ia molecular pool.

    Roberto S. Accolla;Nicole Gross;Stefan Carrel;Giorgio Corte

  • Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells.

    A. de Paulis;R. De Palma;L. Di Gioia;M. Carfora

  • Mucosal Immune Response in BNT162b2 COVID-19 Vaccine Recipients

    Lorenzo Azzi;Daniela Dalla Gasperina;Giovanni Veronesi;Mariam Shallak

Frequent Co-Authors

Guido Poli
Guido Poli Vita-Salute San Raffaele University
Silvano Ferrini
Silvano Ferrini University of Genoa
Elisa Vicenzi
Elisa Vicenzi Vita-Salute San Raffaele University
Luigi Buonaguro
Luigi Buonaguro Fondazione IRCCS Istituto Nazionale dei Tumori
Maria Cristina Mingari
Maria Cristina Mingari University of Genoa
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Antoine Gessain
Antoine Gessain Institut Pasteur
Eric O. Long
Eric O. Long National Institutes of Health
Giorgio Corte
Giorgio Corte University of Genoa
Bernard Mach
Bernard Mach University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare fields can open diverse career opportunities. Many students transition from immunology studies into nursing, with specialized paths available for non-nurses through online nursing programs for non nurses. These options provide a flexible way to enter the nursing profession without prior experience.

Accelerated Bachelor of Science in Nursing (ABSN) programs with high acceptance rates offer another accessible route. These programs are designed for individuals with a non-nursing bachelor’s degree aiming to fast-track their clinical careers and can be a practical option for immunology graduates considering nursing roles. See more about absn programs with high acceptance rates.

Licensed Practical Nurse (LPN) programs provide a quicker, entry-level pathway into patient care, complementing immunology expertise in clinical settings. If you’re looking for the fastest options, explore fastest and easiest lpn programs to get started.

For those seeking advanced practice roles, nurse practitioner programs with easy admission can be an ideal next step, blending immunology knowledge with advanced clinical skills. Check out nurse practitioner programs with easy admission to find suitable options.

Best Scientists Citing Roberto S. Accolla

Trending Scientists

Recently Published Articles